Industry

Policy on the Use of Standard Formulation of Extemporaneous / Galenical / Sterile Preparation and Practice and Procedure on Drug Formulation Request for Extemporaneous/ Galenical/ Sterile Preparation

Date: 15 October 2023 - 5:11am

The Policy on the Use of Standard Formulation of Extemporaneous / Galenical / Sterile Preparation and Practice and Procedure on Drug Formulation Request for Extemporaneous/ Galenical/ Sterile Preparation are established to ensure that each application submitted by pharmacist in MOH facilities follows a systematic procedure.

English

Quality Objectives Achievement 2022

Date: 15 October 2023 - 5:17am

Achievement Period: January - December 2022

 

Pharmacy Policy & Strategic Planning Division

No.

Quality Objectives

Date: 30 May 2025 - 8:10pm

QUALITY OBJECTIVES PHARMACEUTICAL SERVICES PROGRAMME, MOH 2025

 

Pharmacy Policy & Strategic Planning Division

No

Indicator

Target

1.

Percentage of Pharmacists and Pharmacists Assistant who have achieved the minimum annual CPD requirement set (Pharmaceutical Services Programme MOH)

100%

National Oncology Pharmacy Conference 2023

Location/place: 
Institut Kanser Negara
Date: 
Wednesday, 15 March 2023 to Friday, 17 March 2023

Position Statements on the Use of Biosimilars in the Ministry of Health, Malaysia Healthcare Facilities

Date: 15 October 2023 - 5:21am

The increasing use of biological medicines including biosimilars in the Ministry of Health (MOH), Malaysia facilities warrants a suitable guidance document to ensure safe

English

#MedSafetyWeek 2022

During the annual #MedSafetyWeek global campaign, National Pharmaceutical Regulatory Agency (NPRA) collaborates with the Uppsala Monitoring Centre (UMC, the World Health Organisation (WHO) Collaborating Centre for International Drug Monitoring), medicines regulatory authorities, and national pharmacovigilance centres around the world to raise awareness of medication safety and encourage reporting of suspected adverse drug reactions/adverse events following immunisation (ADR/AEFI).

Location/place: 
Online
Date: 
Monday, 7 November 2022 to Sunday, 13 November 2022

PENGUMUMAN: GARIS PANDUAN KELULUSAN PENGIKLANAN PRODUK BERDAFTAR

Date: 15 October 2023 - 5:21am

Garis Panduan ini adalah digunakan sebagai rujukan/panduan tentang perkara-perkara yang harus dipatuhi dalam merangka iklan produk ubat berdaftar untuk kelulusan Lembaga Iklan Ubat. Garis Panduan ini akan mengganti Garis Panduan Pengiklanan Ubat dan Produk Perubatan kepada Orang Ramai. Tarikh penguatkuasaan garis panduan ini adalah pada 1 Oktober 2022.  

Sekiranya tuan/puan mempunyai sebarang pertanyaan lanjut, sila hubungi Sekretariat Lembaga Iklan Ubat di talian 03-78413200 atau melalui emel liu@moh.gov.my.
 

Pages